Back to Results

Phase II Trial to Evaluate Safety and Efficacy of GM-CSF/Sargramostim in Alzheimer's Disease (SESAD)

Study category: Brain and Nervous System

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Type of Study

Treatment

Locations

Brain Imaging Center (BIC)
C-TRIC
Outpatient CTRC
University of Colorado Hospital

Principal Investigator
Peter Pressman,  MD

Peter Pressman, MD

Study ID

Protocol Number: 19-2727

More information available at ClinicalTrials.gov: NCT04902703

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers